Related references
Note: Only part of the references are listed.Pathogenesis of thrombotic microangiopathies
X. Long Zheng et al.
ANNUAL REVIEW OF PATHOLOGY-MECHANISMS OF DISEASE (2008)
The combined roles of ADAMTS13 and VWF in murine models of TTP, endotoxemia, and thrombosis
Anil K. Chauhan et al.
BLOOD (2008)
Platelet-VWF complexes are preferred substrates of ADAMTS13 under fluid shear stress
Kyuhwan Shim et al.
BLOOD (2008)
Functional imaging of shear-dependent activity of ADAMTS13 in regulating mural thrombus growth under whole blood flow conditions
Yasuaki Shida et al.
BLOOD (2008)
The cooperative activity between the carboxyl-terminal TSP1 repeats and the CUB domains of ADAMTS13 is crucial for recognition of von Willebrand factor under flow
Ping Zhang et al.
BLOOD (2007)
An IAP retrotransposon in the mouse ADAMTS13 gene creates ADAMTS 13 variant proteins that are less effective in cleaving von Willebrand factor multimers
Wenhua Zhou et al.
BLOOD (2007)
Thrombotic thrombocytopenic purpura: A thrombotic disorder caused by ADAMTS 13 deficiency
Han-Mou Tsai
HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA (2007)
Thrombotic thrombocytopenic purpura in humans and mice
Karl C. Desch et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2007)
Exosite interactions contribute to tension-induced cleavage of von Willebrand factor by the antithrombotic ADAMTS13 metalloprotease
Weiqiang Gao et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Distinct antithrombotic consequences of platelet glycoprotein Ibα and VI deficiency in a mouse model of arterial thrombosis
S. Konstantinides et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2006)
Complete deficiency in ADAMTS13 is prothrombotic, but it alone is not sufficient to cause thrombotic thrombocytopenic purpura
F Banno et al.
BLOOD (2006)
Systemic antithrombotic effects of ADAMTS13
AK Chauhan et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2006)
Size regulation of von Willebrand factor-mediated platelet thrombi by ADAMTS13 in flowing blood
R Donadelli et al.
BLOOD (2006)
Recombinant CUB-1 domain polypeptide inhibits the cleavage of ULVWF strings by ADAMTS13 under flow conditions
ZY Tao et al.
BLOOD (2005)
Shigatoxin triggers thrombotic thrombocytopenic purpura in genetically susceptible ADAMTS13-deficient mice
DG Motto et al.
JOURNAL OF CLINICAL INVESTIGATION (2005)
The proximal carboxyl-terminal domains of ADAMTS13 determine substrate specificity and are all required for cleavage of von Willebrand factor
JH Ai et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Cleavage of ultralarge multimers of von Willebrand factor by C-terminal-truncated mutants of ADAMTS-13 under flow
ZY Tao et al.
BLOOD (2005)
Binding of ADAMTS13 to von Willebrand factor
EM Majerus et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
FRETS-VWF73, a first fluorogenic substrate for ADAMTS13 assay
K Kokame et al.
BRITISH JOURNAL OF HAEMATOLOGY (2005)
VWF73, a region from D1596 to R1668 of von Willebrand factor, provides a minimal substrate for ADAMTS-13
K Kokame et al.
BLOOD (2004)
Binding of platelet glycoprotein Ibα to von Willebrand factor domain A1 stimulates the cleavage of the adjacent domain A2 by ADAMTS13
K Nishio et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Identification of strain-specific variants of mouse Adamts13 gene encoding von Willebrand factor-cleaving protease
F Banno et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Cleavage of von Willebrand factor requires the spacer domain of the metalloprotease ADAMTS13
XL Zheng et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
ADAMTS-13 cysteine-rich/spacer domains are functionally essential for von Willebrand factor cleavage
K Soejima et al.
BLOOD (2003)
Characterization of a mouse model for thrombomodulin deficiency
H Weiler et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2001)
Variable protection of β3-integrin-deficient mice from thrombosis initiated by different mechanisms
SS Smyth et al.
BLOOD (2001)
Share Paper
